BioScience Laboratories Announces Testing Capabilities To Support Approved Health Canada Guidance Document For Human-Use Antiseptic Drugs

    BOZEMAN, MT, December 31, 2009 /24-7PressRelease/ -- BioScience Laboratories announces efficacy and safety testing capabilities to support Health Canada's guidance document Human-Use Antiseptic Drugs finalized on December 2, 2009. BioScience Laboratories actively participated in the development and revision of this document. The organization's Clinical and In-Vitro Laboratories have the training and experience to conduct the testing methods in accordance with CEN, ASTM, and ICH guidelines, as required in this document to show product efficacy and safety. BioScience Laboratories' GCP and GLP compliant quality system ensures that the testing documentation generated will meet Health Canada's requirements for submission to support product efficacy and safety claims.

For more information on BioScience Laboratories' capabilities to perform the testing outlined in the Health Canada Human-Use Antiseptic Drugs guidance document, contact:

John Dyba
Senior Account Executive
1-877-858-2754
[email protected]
http://www.biosciencelabs.com

About BioScience Laboratories, Inc.

BioScience Laboratories, Inc. was founded in 1991 in Bozeman, MT, to provide antimicrobial product testing and result interpretation grounded in science. Bioscience Laboratories Inc. strives to assist its clients in strengthening their current market positions through product testing and aid in the development of new products and new markets. Today, BioScience Laboratories offers a variety of state-of-the-art laboratory services and guidance regarding federal regulatory agency requirements for the healthcare, pharmaceutical, personal care and consumer products markets.

# # #